...very bold in the approval, and I think it is an important task to see whether it does, in fact, control spend while not being detrimental to access."
—Jeff Myers, senior vice president at Catalyst Healthcare
Consulting, Inc. and former CEO of Medicaid Health Plans of America, spoke with
AIS’s Radar on Drug Benefits about the long odds facing Tennessee’s closed
Medicaid formulary program.
No comments:
Post a Comment